Summary
Kura Oncology
Founded in 2014
Description
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and developme...
Strengths
- Kura Oncology has a strong market share in their industry
- Since Kura Oncology was founded, the company has grown faster than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
Annual Revenue
Kura Oncology's annual revenue
$23074000
Based on Kona Equity data
-
Revenue per employee
$173489
-
Annual revenue growth since founding
$2307400
Employee Count
133 employees
Executives
Dipanjan Sengupta
Associate Director, Api Process R& D, CMC
d**@kuraoncology.comFrancis Burrows
Vice President, Translational Research
f**@kuraoncology.comPhone Oncology
President & Chief Executive Officer
p**@kuraoncology.comXuefeng Zhu
Senior Director of Medicinal Chemistry
x**@kuraoncology.comPete Spain
Senior VP, Investor Relations, Corporate Communications
p**@kuraoncology.comKathleen Ford
Chief Operating Officer
k**@kuraoncology.comTania Reyes
Controller
t**@kuraoncology.comHolly Sepa
Senior Director
h**@kuraoncology.comKirsten Flowers
Chief Commercial Officer
k**@kuraoncology.comRoger Bakale
Vice President & Head of CMC, Clinical & Commercial Manufacturing
r**@kuraoncology.comTroy Wilson
President & Chief Executive Officer
t**@kuraoncology.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Epizyme, Inc.
epizyme.com- Founded in 2007
- Location: Cambridge, Massachusetts
- Annual Revenue: $38.5M
- Employees: 250
- Epizyme is a biopharmaceutical company that focuses on the discovery, development, and commercialization of epigenetic therapies for cancer patients.
Syndax Pharmaceuticals
syndax.com- Founded in 2005
- Location: Waltham, MA
- Annual Revenue: $139.3M
- Employees: 59
- Syndax Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Companys product candidate, entinostat, which was granted Breakthrough Therapy designati...
Otonomy
otonomy.com- Founded in 2008
- Location: San Diego, CA
- Annual Revenue: $35.0K
- Employees: 51
- In 2008, Jay Lichter, Ph.D., a partner at Avalon Ventures and biotechnology industry veteran, experienced his first severe attack of vertigo. While driving, he became severely disoriented and had to pull to the side of the road. After multiple doctor v...
BeyondSpring
beyondspringpharma.com- Founded in 2010
- Location: New York, NY
- Annual Revenue: $1.4M
- Employees: 103
- BeyondSpring Inc. is a global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes. They have a robust pipeline of products developed internally and through collaboration with the University of Washin...
G1 Therapeutics
g1therapeutics.com- Founded in 2008
- Location: Durham, NC
- Annual Revenue: $24.2M
- Employees: 148
- G1 Therapeutics, Inc. is an American biopharmaceutical company headquartered in Research Triangle Park, North Carolina.
Trevena Inc
trevenainc.com- Founded in 2007
- Location: King of Prussia, Pennsylvania
- Annual Revenue: $378.0K
- Employees: 43
- Trevena Inc is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors biased ligands.
Key Information
- Name: Kura Oncology
- Category: Biotechnology
- Industry: Biotechnology company
- SIC: 28; 283
- NAICS: 32; 325
See similar companies
-
By City San Diego Small Biotechnology company in San Diego Mid-size Biotechnology company in San Diego Biotechnology in San Diego Small Biotechnology in San Diego Mid-size Biotechnology in San Diego
-
By State CA Small companies in CA Biotechnology in CA Small Biotechnology in CA Mid-size Biotechnology in CA Small Biotechnology company in CA Mid-size Biotechnology company in CA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology company Small Biotechnology company Mid-size Biotechnology company Biotechnology and Biotechnology company
-
Firmographic data G Score of 2 Founded in 2014 SIC: 28 SIC: 283 NAICS: 32 NAICS: 325 #Manufacturing #Pharmaceuticals #Business Services #Research & Development
Frequently Asked Questions
Kura Oncology's headquarters are located at 12730 High Bluff Dr Ste 400 San Diego, CA 92130.
Kura Oncology's official website is kuraoncology.com
Kura Oncology's annual revenue is $23.1 M.
Kura Oncology's SIC: 28; 283
Kura Oncology's NAICS: 32; 325.
Kura Oncology has 133 employees
Kura Oncology is in the industry of Biotechnology.
